MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 

2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions
View by Date

Thursday, June 8, 2017

1:15pm-2:45pm
The effects of wearing usual indoor and outdoor footwear on balance and gait performance in people with Parkinson’s disease using clinical tests and instrumented movement analysis.

D. Kunkel, M. Burnett, L. Mamode, R. Pickering, C. Bowen, D. Bader, J. Robison, M. Donovan-Hall, M. Cole, A. Ashburn (Southampton, United Kingdom)

Other  ·  Exhibit Hall C
1:15pm-2:45pm
The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease

M. Nagai, M. Kubo, H. Iwaki, R. Ando, M. Nomoto (Ehime, Japan)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C
1:15pm-2:45pm
The Importance of Ultrasonographic Evaluation in the Diagnosis of Dysphagia in Parkinson Disease

E. Umay, E. Ozturk, I. Gundogdu, O. Delibas, B. Gonenli, A. Cakci (Ankara, Turkey)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C
1:15pm-2:45pm
The influence of LRRK2 mutations on cholinergic system in manifest and prodromal stage of Parkinson’s disease: a positron emission tomography study

S. [email protected], D. Wile, J. Fu, J. Valerio, E. Shahinfard, S. McCormick, R. Mabrouk, N. Vafai, J. McKenzie, N. Neilson, A. Perez-Soriano, J. Arena, M. Cherkasova, J. Zhang, C. Zabetian, J. Aasly, Z. Wszolek, M. McKeown, V. Sossi, A. Stoessl (Beijing, China)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Exhibit Hall C
1:15pm-2:45pm
The involvement of primary olfactory cortex in olfactory deficits in early-stage Parkinson’s disease

J. Wang, T. Subramanian, Q. Yang (Hershey, PA, USA)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Exhibit Hall C
1:15pm-2:45pm
The landscape of interventional trials in Parkinson disease: A 10-year review of ClinicalTrials.gov between 2006 and 2016

K. Wyant, E. Yasuda, V. Kotagal (Ann Arbor, MI, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C
1:15pm-2:45pm
The management of Parkinson’s disease in the Middle East countries: the MDS-middle east task force survey

H. Khalil, Z. Aldaajani, S. Baudry, M. Abualmelh, T. Mohammad, M. Salari, M. Bhatt, S. Tabbal, N.A. Syed, B. Jeon, C. Goetz, J.A. Bajwa (Irbid, Jordan)

Other  ·  Exhibit Hall C
1:15pm-2:45pm
The occurrence of dopamine-responsive and dopamine-resistant resting tremor in Parkinson’s disease

H. Zach, M. Dirkx, D. Roth, j. Pasman, B. Bloem, R. Helmich (Nijmegen, Netherlands)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C
1:15pm-2:45pm
The prevalence of cerebral microbleeds in patients with Parkinson’s disease and multiple system atrophy

J.-M. Kim (Seongnam, Republic of Korea)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Exhibit Hall C
1:15pm-2:45pm
The Pull Test in healthy subjects and Parkinson´s disease: quantitative pull-force measure, postugraphic and electromyographic analysis

J.R. Perez-Sanchez, B. DeLaCasa-Fages, A. Contreras, J.M. Velázquez, A. Muñoz-González, F. Grandas (Madrid, Spain)

Other  ·  Exhibit Hall C